| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 46.318.247 $ | 99,84 | 4.463.906 | |||||||
| FIRST TRACKS BIOTHERAPEUTICS INC | FIRST TRACKS BIOTHERAPEUTICS INC ORD SHS | EC | 337185102 | Long | Börsenkurs (Stufe 1) | 775.985 $ | 1,67 | 17.620 | |
| MBX BIOSCIENCES INC | MBX BIOSCIENCES INC COM | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 577.151 $ | 1,24 | 8.754 | |
| ATAIBECKLEY INC | ATAIBECKLEY INC COM SHS | EC | 04650F101 | Long | Börsenkurs (Stufe 1) | 569.295 $ | 1,23 | 79.289 | |
| MONOPAR THERAPEUTICS INC | MONOPAR THERAPEUTICS INC COM NEW | EC | 61023L207 | Long | Börsenkurs (Stufe 1) | 563.420 $ | 1,21 | 5.200 | |
| DEFINIUM THERAPEUTICS INC | DEFINIUM THERAPEUTICS INC COM SHS | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 546.524 $ | 1,18 | 12.558 | |
| XENCOR INC | XENCOR INC COM | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 509.454 $ | 1,10 | 25.208 | |
| ZENAS BIOPHARMA INC | ZENAS BIOPHARMA INC COM | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 493.514 $ | 1,06 | 15.697 | |
| UNIQURE NV | UNIQURE NV SHS | EC | NL0010696654 | Long | Börsenkurs (Stufe 1) | 491.841 $ | 1,06 | 11.273 | |
| APOGEE THERAPEUTICS INC | APOGEE THERAPEUTICS INC COM | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 471.863 $ | 1,02 | 3.519 | |
| VOR BIOPHARMA INC | VOR BIOPHARMA INC COM NEW | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 457.771 $ | 0,99 | 21.644 | |
| REGENXBIO INC | REGENXBIO INC COM | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 452.232 $ | 0,97 | 46.670 | |
| LB PHARMACEUTICALS INC | LB PHARMACEUTICALS INC COM SHS | EC | 50180M108 | Long | Börsenkurs (Stufe 1) | 438.315 $ | 0,94 | 10.936 | |
| DAMORA THERAPEUTICS INC | DAMORA THERAPEUTICS INC COM USD0.00001 | EC | KYG2646Y1044 | Long | Börsenkurs (Stufe 1) | 433.603 $ | 0,93 | 14.957 | |
| AMYLYX PHARMACEUTICALS INC | AMYLYX PHARMACEUTICALS INC COM | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 432.664 $ | 0,93 | 21.303 | |
| DYNE THERAPEUTICS INC | DYNE THERAPEUTICS INC COM | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 430.251 $ | 0,93 | 17.087 | |
| ORUKA THERAPEUTICS INC | ORUKA THERAPEUTICS INC COM | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 429.180 $ | 0,93 | 4.447 | |
| NURIX THERAPEUTICS INC | NURIX THERAPEUTICS INC COM | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 425.602 $ | 0,92 | 18.337 | |
| ORIC PHARMACEUTICALS INC | ORIC PHARMACEUTICALS INC COM | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 416.066 $ | 0,90 | 37.585 | |
| GH RESEARCH PLC | GH RESEARCH PLC ORDINARY SHARES | EC | IE000GID8VI0 | Long | Börsenkurs (Stufe 1) | 413.078 $ | 0,89 | 14.716 | |
| SIONNA THERAPEUTICS INC | SIONNA THERAPEUTICS INC COM | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 407.816 $ | 0,88 | 8.653 | |
| DIANTHUS THERAPEUTICS INC | DIANTHUS THERAPEUTICS INC COM | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 404.906 $ | 0,87 | 3.787 | |
| ERASCA INC | ERASCA INC COM | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 401.514 $ | 0,87 | 22.122 | |
| JADE BIOSCIENCES INC | JADE BIOSCIENCES INC COM NEW | EC | 008064206 | Long | Börsenkurs (Stufe 1) | 400.155 $ | 0,86 | 20.261 | |
| SELLAS LIFE SCIENCES GROUP INC | SELLAS LIFE SCIENCES GROUP INC COM NEW | EC | 81642T209 | Long | Börsenkurs (Stufe 1) | 397.347 $ | 0,86 | 39.695 | |
| PALVELLA THERAPEUTICS INC | PALVELLA THERAPEUTICS INC COM | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 397.098 $ | 0,86 | 2.856 | |
| RELAY THERAPEUTICS INC | RELAY THERAPEUTICS INC COM | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 395.223 $ | 0,85 | 20.989 | |
| REPLIMUNE GROUP INC | REPLIMUNE GROUP INC COM | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 392.011 $ | 0,84 | 35.001 | |
| ALTO NEUROSCIENCE INC | ALTO NEUROSCIENCE INC COM SHS | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 391.865 $ | 0,84 | 14.476 | |
| ADLAI NORTYE LTD | ADLAI NORTYE LTD SPONSORED ADS | EC | 00704R109 | Long | Börsenkurs (Stufe 1) | 391.521 $ | 0,84 | 30.117 | |
| BICARA THERAPEUTICS INC | BICARA THERAPEUTICS INC COM | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 388.370 $ | 0,84 | 14.331 | |
| IMMUNOME INC | IMMUNOME INC COM | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 384.894 $ | 0,83 | 16.911 | |
| AVALO THERAPEUTICS INC | AVALO THERAPEUTICS INC COM NEW | EC | 05338F306 | Long | Börsenkurs (Stufe 1) | 384.309 $ | 0,83 | 21.058 | |
| MEIRAGTX HOLDINGS PLC | MEIRAGTX HOLDINGS PLC COM | EC | KYG596651029 | Long | Börsenkurs (Stufe 1) | 382.114 $ | 0,82 | 32.410 | |
| IDEAYA BIOSCIENCES INC | IDEAYA BIOSCIENCES INC COM | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 380.738 $ | 0,82 | 10.725 | |
| SPYGLASS PHARMA INC | SPYGLASS PHARMA INC COM SHS | EC | 85220G109 | Long | Börsenkurs (Stufe 1) | 379.743 $ | 0,82 | 16.855 | |
| KODIAK SCIENCES INC | KODIAK SCIENCES INC COM | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 379.418 $ | 0,82 | 9.125 | |
| REVOLUTION MEDICINES INC | REVOLUTION MEDICINES INC COM | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 378.811 $ | 0,82 | 2.020 | |
| CELLDEX THERAPEUTICS INC | CELLDEX THERAPEUTICS INC COM NEW | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 378.316 $ | 0,82 | 9.940 | |
| SPYRE THERAPEUTICS INC | SPYRE THERAPEUTICS INC COM NEW | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 378.276 $ | 0,82 | 3.847 | |
| CULLINAN THERAPEUTICS INC | CULLINAN THERAPEUTICS INC COM | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 374.336 $ | 0,81 | 22.687 | |
| LEXICON PHARMACEUTICALS INC | LEXICON PHARMACEUTICALS INC COM NEW | EC | 528872302 | Long | Börsenkurs (Stufe 1) | 373.947 $ | 0,81 | 161.882 | |
| XENON PHARMACEUTICALS INC | XENON PHARMACEUTICALS INC COM | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 373.889 $ | 0,81 | 5.966 | |
| KYMERA THERAPEUTICS INC | KYMERA THERAPEUTICS INC COM | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 372.757 $ | 0,80 | 3.605 | |
| BIOHAVEN LTD | BIOHAVEN LTD COM | EC | VGG1110E1079 | Long | Börsenkurs (Stufe 1) | 371.979 $ | 0,80 | 27.554 | |
| CG ONCOLOGY INC | CG ONCOLOGY INC COM | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 371.469 $ | 0,80 | 5.218 | |
| NEKTAR THERAPEUTICS | NEKTAR THERAPEUTICS COM NEW | EC | 640268306 | Long | Börsenkurs (Stufe 1) | 369.887 $ | 0,80 | 5.234 | |
| ENLIVEN THERAPEUTICS INC | ENLIVEN THERAPEUTICS INC COM | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 369.310 $ | 0,80 | 6.738 | |
| ARCUS BIOSCIENCES INC | ARCUS BIOSCIENCES INC COM | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 368.161 $ | 0,79 | 13.060 | |
| TYRA BIOSCIENCES INC | TYRA BIOSCIENCES INC COM | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 367.130 $ | 0,79 | 11.516 | |
| REZOLUTE INC | REZOLUTE INC COM NEW | EC | 76200L309 | Long | Börsenkurs (Stufe 1) | 366.768 $ | 0,79 | 77.705 | |
| COGENT BIOSCIENCES INC | COGENT BIOSCIENCES INC COM | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 365.553 $ | 0,79 | 9.390 | |
| ALUMIS INC | ALUMIS INC COM | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 363.578 $ | 0,78 | 12.870 | |
| CANDEL THERAPEUTICS INC | CANDEL THERAPEUTICS INC COM | EC | 137404109 | Long | Börsenkurs (Stufe 1) | 363.463 $ | 0,78 | 36.310 | |
| SANA BIOTECHNOLOGY INC | SANA BIOTECHNOLOGY INC COM | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 363.005 $ | 0,78 | 115.976 | |
| ACHIEVE LIFE SCIENCES INC | ACHIEVE LIFE SCIENCES INC COM | EC | 004468500 | Long | Börsenkurs (Stufe 1) | 361.497 $ | 0,78 | 56.308 | |
| OLEMA PHARMACEUTICALS INC | OLEMA PHARMACEUTICALS INC COM | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 360.561 $ | 0,78 | 31.490 | |
| VIRIDIAN THERAPEUTICS INC | VIRIDIAN THERAPEUTICS INC COM | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 359.669 $ | 0,78 | 19.010 | |
| PRAXIS PRECISION MEDICINES INC | PRAXIS PRECISION MEDICINES INC COM NEW | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 358.930 $ | 0,77 | 1.166 | |
| 4D MOLECULAR THERAPEUTICS INC | 4D MOLECULAR THERAPEUTICS INC COM | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 358.326 $ | 0,77 | 35.199 | |
| IMMUNOVANT INC | IMMUNOVANT INC COM | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 357.042 $ | 0,77 | 9.245 | |
| BELITE BIO INC | BELITE BIO INC SPONSORED ADS | EC | 07782B104 | Long | Börsenkurs (Stufe 1) | 356.873 $ | 0,77 | 2.250 | |
| VAXCYTE INC | VAXCYTE INC COM | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 354.170 $ | 0,76 | 6.549 | |
| DISC MEDICINE INC | DISC MEDICINE INC COM | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 351.967 $ | 0,76 | 4.571 | |
| ROCKET PHARMACEUTICALS INC | ROCKET PHARMACEUTICALS INC COM | EC | 77313F106 | Long | Börsenkurs (Stufe 1) | 351.505 $ | 0,76 | 113.024 | |
| GENERATE BIOMEDICINES INC | GENERATE BIOMEDICINES INC COM SHS | EC | 370920100 | Long | Börsenkurs (Stufe 1) | 351.484 $ | 0,76 | 25.106 | |
| NEUROGENE INC | NEUROGENE INC COM | EC | 64135M105 | Long | Börsenkurs (Stufe 1) | 351.298 $ | 0,76 | 10.681 | |
| SOLID BIOSCIENCES INC | SOLID BIOSCIENCES INC COM NEW | EC | 83422E204 | Long | Börsenkurs (Stufe 1) | 350.860 $ | 0,76 | 43.531 | |
| MAZE THERAPEUTICS INC | MAZE THERAPEUTICS INC COM | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 347.914 $ | 0,75 | 12.924 | |
| STRUCTURE THERAPEUTICS INC | STRUCTURE THERAPEUTICS INC SPONSORED ADS | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 347.810 $ | 0,75 | 7.240 | |
| JANUX THERAPEUTICS INC | JANUX THERAPEUTICS INC COM | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 347.742 $ | 0,75 | 22.923 | |
| CORVUS PHARMACEUTICALS INC | CORVUS PHARMACEUTICALS INC COM | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 345.476 $ | 0,74 | 26.054 | |
| DESIGN THERAPEUTICS INC | DESIGN THERAPEUTICS INC COM | EC | 25056L103 | Long | Börsenkurs (Stufe 1) | 345.096 $ | 0,74 | 28.333 | |
| VIKING THERAPEUTICS INC | VIKING THERAPEUTICS INC COM | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 343.141 $ | 0,74 | 10.811 | |
| EDGEWISE THERAPEUTICS INC | EDGEWISE THERAPEUTICS INC COM | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 342.988 $ | 0,74 | 8.925 | |
| AURA BIOSCIENCES INC | AURA BIOSCIENCES INC COM | EC | 05153U107 | Long | Börsenkurs (Stufe 1) | 339.915 $ | 0,73 | 48.490 | |
| ASSEMBLY BIOSCIENCES INC | ASSEMBLY BIOSCIENCES INC COM NEW | EC | 045396207 | Long | Börsenkurs (Stufe 1) | 339.914 $ | 0,73 | 13.537 | |
| VERADERMICS INC | VERADERMICS INC COMMON STOCK | EC | 922967104 | Long | Börsenkurs (Stufe 1) | 339.675 $ | 0,73 | 3.235 | |
| ABCELLERA BIOLOGICS INC | ABCELLERA BIOLOGICS INC COM | EC | 00288U106 | Long | Börsenkurs (Stufe 1) | 338.689 $ | 0,73 | 59.315 | |
| ALTIMMUNE INC | ALTIMMUNE INC COM NEW | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 338.204 $ | 0,73 | 119.086 | |
| ANNEXON INC | ANNEXON INC COM | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 336.214 $ | 0,72 | 65.989 | |
| MINERALYS THERAPEUTICS INC | MINERALYS THERAPEUTICS INC COM | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 335.818 $ | 0,72 | 13.159 | |
| SCHOLAR ROCK HOLDING CORP | SCHOLAR ROCK HOLDING CORP COM | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 332.720 $ | 0,72 | 7.035 | |
| RAPPORT THERAPEUTICS INC | RAPPORT THERAPEUTICS INC COM | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 331.692 $ | 0,71 | 8.094 | |
| PHARVARIS NV | PHARVARIS NV COM | EC | NL00150005Y4 | Long | Börsenkurs (Stufe 1) | 330.049 $ | 0,71 | 10.118 | |
| ARVINAS INC | ARVINAS INC COM | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 329.262 $ | 0,71 | 41.004 | |
| PRIME MEDICINE INC | PRIME MEDICINE INC COM | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 327.052 $ | 0,70 | 112.004 | |
| BRIDGEBIO ONCOLOGY THERAPEUTICS INC | BRIDGEBIO ONCOLOGY THERAPEUTICS INC COM NEW | EC | 107924102 | Long | Börsenkurs (Stufe 1) | 324.466 $ | 0,70 | 40.107 | |
| CLIMB BIO INC | CLIMB BIO INC COM | EC | 28658R106 | Long | Börsenkurs (Stufe 1) | 323.335 $ | 0,70 | 27.171 | |
| SAVARA INC | SAVARA INC COM | EC | 805111101 | Long | Börsenkurs (Stufe 1) | 322.631 $ | 0,70 | 59.090 | |
| UPSTREAM BIO INC | UPSTREAM BIO INC COM | EC | 91678A107 | Long | Börsenkurs (Stufe 1) | 321.507 $ | 0,69 | 50.952 | |
| CYTOMX THERAPEUTICS INC | CYTOMX THERAPEUTICS INC COM | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 320.103 $ | 0,69 | 103.259 | |
| TAYSHA GENE THERAPIES INC | TAYSHA GENE THERAPIES INC COM SHS | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 318.977 $ | 0,69 | 54.433 | |
| OCULIS HOLDING AG | OCULIS HOLDING AG ORDINARY SHARES | EC | CH1242303498 | Long | Börsenkurs (Stufe 1) | 316.985 $ | 0,68 | 28.027 | |
| ARBUTUS BIOPHARMA CORP | ARBUTUS BIOPHARMA CORP COM | EC | 03879J100 | Long | Börsenkurs (Stufe 1) | 316.655 $ | 0,68 | 72.962 | |
| AKTIS ONCOLOGY INC | AKTIS ONCOLOGY INC COM | EC | 01021M104 | Long | Börsenkurs (Stufe 1) | 312.798 $ | 0,67 | 14.173 | |
| VIR BIOTECHNOLOGY INC | VIR BIOTECHNOLOGY INC COM | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 312.617 $ | 0,67 | 36.099 | |
| ALLOGENE THERAPEUTICS INC | ALLOGENE THERAPEUTICS INC COM | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 307.542 $ | 0,66 | 163.586 | |
| MOONLAKE IMMUNOTHERAPEUTICS | MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | EC | 61559X104 | Long | Börsenkurs (Stufe 1) | 306.657 $ | 0,66 | 16.630 | |
| IMMIX BIOPHARMA INC | IMMIX BIOPHARMA INC COM | EC | 45258H106 | Long | Börsenkurs (Stufe 1) | 306.026 $ | 0,66 | 36.782 | |
| PROTHENA CORP PLC | PROTHENA CORP PLC SHS | EC | IE00B91XRN20 | Long | Börsenkurs (Stufe 1) | 305.913 $ | 0,66 | 37.674 | |
| ARRIVENT BIOPHARMA INC | ARRIVENT BIOPHARMA INC COM | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 303.478 $ | 0,65 | 10.177 | |
| CELCUITY INC | CELCUITY INC COM | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 303.194 $ | 0,65 | 3.510 | |
| STOKE THERAPEUTICS INC | STOKE THERAPEUTICS INC COM | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 300.808 $ | 0,65 | 10.423 | |
| SEPTERNA INC | SEPTERNA INC COM | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 297.855 $ | 0,64 | 8.646 | |
| BICYCLE THERAPEUTICS PLC | BICYCLE THERAPEUTICS PLC SPONSORED ADS | EC | 088786108 | Long | Börsenkurs (Stufe 1) | 296.228 $ | 0,64 | 76.743 | |
| RECURSION PHARMACEUTICALS INC | RECURSION PHARMACEUTICALS INC CL A | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 296.010 $ | 0,64 | 98.670 | |
| ANAPTYSBIO INC | ANAPTYSBIO INC COM | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 295.774 $ | 0,64 | 5.543 | |
| LEXEO THERAPEUTICS INC | LEXEO THERAPEUTICS INC COM | EC | 52886X107 | Long | Börsenkurs (Stufe 1) | 293.742 $ | 0,63 | 71.124 | |
| COMPASS THERAPEUTICS INC | COMPASS THERAPEUTICS INC COM | EC | 20454B104 | Long | Börsenkurs (Stufe 1) | 292.440 $ | 0,63 | 153.110 | |
| EYEPOINT INC | EYEPOINT INC COM NEW | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 292.199 $ | 0,63 | 23.853 | |
| COMPASS PATHWAYS PLC | COMPASS PATHWAYS PLC SPONSORED ADS | EC | 20451W101 | Long | Börsenkurs (Stufe 1) | 292.047 $ | 0,63 | 25.731 | |
| PROKIDNEY CORP | PROKIDNEY CORP SHS CL A | EC | 74291D104 | Long | Börsenkurs (Stufe 1) | 291.861 $ | 0,63 | 189.520 | |
| WAVE LIFE SCIENCES LTD | WAVE LIFE SCIENCES LTD SHS | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 291.760 $ | 0,63 | 52.951 | |
| VERA THERAPEUTICS INC | VERA THERAPEUTICS INC CL A | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 291.211 $ | 0,63 | 9.072 | |
| SUMMIT THERAPEUTICS INC | SUMMIT THERAPEUTICS INC COM | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 288.849 $ | 0,62 | 22.185 | |
| TECTONIC THERAPEUTIC INC | TECTONIC THERAPEUTIC INC COM | EC | 878972108 | Long | Börsenkurs (Stufe 1) | 287.728 $ | 0,62 | 10.265 | |
| IMMATICS NV | IMMATICS NV SHS | EC | NL0015285941 | Long | Börsenkurs (Stufe 1) | 286.949 $ | 0,62 | 33.135 | |
| NEWAMSTERDAM PHARMA COMPANY NV | NEWAMSTERDAM PHARMA COMPANY NV ORDINARY SHARES | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 284.125 $ | 0,61 | 10.224 | |
| MONTE ROSA THERAPEUTICS INC | MONTE ROSA THERAPEUTICS INC COM | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 281.583 $ | 0,61 | 17.045 | |
| CABALETTA BIO INC | CABALETTA BIO INC COM | EC | 12674W109 | Long | Börsenkurs (Stufe 1) | 276.734 $ | 0,60 | 103.259 | |
| INHIBRX BIOSCIENCES INC | INHIBRX BIOSCIENCES INC COM | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 276.591 $ | 0,60 | 3.371 | |
| INTELLIA THERAPEUTICS INC | INTELLIA THERAPEUTICS INC COM | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 274.113 $ | 0,59 | 25.666 | |
| BEAM THERAPEUTICS INC | BEAM THERAPEUTICS INC COM | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 273.268 $ | 0,59 | 10.708 | |
| TANGO THERAPEUTICS INC | TANGO THERAPEUTICS INC COM | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 273.050 $ | 0,59 | 10.046 | |
| CRESCENT BIOPHARMA INC | CRESCENT BIOPHARMA INC COM USD0.001 | EC | KYG2545C1042 | Long | Börsenkurs (Stufe 1) | 250.968 $ | 0,54 | 17.344 | |
| RELMADA THERAPEUTICS INC | RELMADA THERAPEUTICS INC COM | EC | 75955J402 | Long | Börsenkurs (Stufe 1) | 248.179 $ | 0,53 | 46.738 | |
| INVIVYD INC | INVIVYD INC COM | EC | 00534A102 | Long | Börsenkurs (Stufe 1) | 215.955 $ | 0,47 | 403.655 | |
| EVOMMUNE INC | EVOMMUNE INC COM SHS | EC | 30054Y107 | Long | Börsenkurs (Stufe 1) | 176.333 $ | 0,38 | 15.674 | |
| BIOAGE LABS INC | BIOAGE LABS INC COM | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 155.750 $ | 0,34 | 17.229 | |
| MAPLIGHT THERAPEUTICS INC | MAPLIGHT THERAPEUTICS INC COM | EC | 56565P103 | Long | Börsenkurs (Stufe 1) | 145.837 $ | 0,31 | 11.201 | |
| CAPRICOR THERAPEUTICS INC | CAPRICOR THERAPEUTICS INC COM NEW | EC | 14070B309 | Long | Börsenkurs (Stufe 1) | 46.381 $ | 0,10 | 12.047 | |
| 46.318.247 $ | 99,84 | 4.463.906 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
aufsichtsrechtlicher Pflichtmeldungen und öffentlicher Register und stellen keine
Bewertung oder Empfehlung zu einzelnen Wertpapieren, Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher Pflichtmeldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.